Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib with WBRT or SRS for HER2+ Breast Cancer Brain Metastases
NCT01622868Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Dec 2012
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of lapatinib in breast cancer, sponsored by National Cancer Institute. Started Dec 2012; status: completed.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01622868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01622868.